Several years ago, it was found that on the surface of immature T cells CD3∈ could be expressed in the apparent absence of TCR chains for antigen, and that signals could be transduced by cross-linking this complex with CD3 antibodies [1](#R1){ref-type="bib"} [2](#R2){ref-type="bib"} [3](#R3){ref-type="bib"}. Since then, it has been discussed whether CD3∈ surface expression in apparent association with calnexin [4](#R4){ref-type="bib"} represents a biological accident without implication for physiological T cell maturation [5](#R5){ref-type="bib"}, or whether it is perhaps indicative of a pro-TCR complex that controls development. This would represent yet another checkpoint, in addition to those controlled by the pre-TCR [6](#R6){ref-type="bib"} and the α/β TCR [7](#R7){ref-type="bib"}. In fact, it was recently argued that the second possibility was likely to be correct, since impaired signal transduction in p56^lck^ and CD3ζ-deficient mice appeared to be associated with reduced expression of productively rearranged TCR-β genes [8](#R8){ref-type="bib"} [9](#R9){ref-type="bib"}. However, it could not be excluded from these studies that the deficiency in TCR-β gene expression was dependent on defective signaling by the pre-TCR or the α/β TCR, since the analysis included thymocyte subsets whose generation depended either on the pre-TCR (some CD25^+^44^−^ cells [10](#R10){ref-type="bib"}) or the α/β TCR (CD25^−^44^+^ NK T cells \[11\]). For that reason, we have analyzed TCR-β expression by intracellular staining in a variety of mutant mouse strains in small CD25^+^44^−^ cells that are independent of the pre-TCR and the α/β TCR. Our data indicate that all differences that exist in TCR-β gene expression among various mouse strains can be attributed to signal transduction by the pre-TCR, since small CD25^+^44^−^ thymocytes of pre-TCR α chain--deficient mice exhibited the same phenotype observed in CD3-deficient mice, thus arguing against a distinct checkpoint in development controlled by the CD3 complex in the absence of the pre-TCR.

Materials and Methods
=====================

Animals.
--------

CD3∈^−/−^, pTα^−/−^, and γc^−/−^ mice have been described [6](#R6){ref-type="bib"} [12](#R12){ref-type="bib"} [13](#R13){ref-type="bib"} and were bred in the specific pathogen--free animal facilities of the Necker Institute, Paris. C57BL/6 and Rag2^−/−^ mice were purchased from Iffa Credo. Animals were analyzed at 6--8 wk of age. Animal care was in accordance with institutional guidelines.

Antibodies and Immunofluorescence Analysis.
-------------------------------------------

The following mAbs were used: CD25 (PC-61) conjugated to FITC, CD44 (Pgp-1)--PE, CD25-PE, CD4 (L3T4)-CyChrome, CD8 (Ly-2)--CyChrome (PharMingen), and anti-pan TCR-β (H57-597). Biotinylated mAbs were revealed with either streptavidin-PE (Southern Biotechnology) or streptavidin-allophycocyanin (APC; Molecular Probes Europe). Cells were stained in microtiter plates (10^6^ cells/well in 50 μl) using combinations of directly conjugated mAbs. Simultaneous four-color cell analyses were performed on a FACSCalibur™ flow cytometer (Becton Dickinson). Dead cells were excluded by gating based on forward and side scatter characteristics.

Intracellular Staining for TCR-*β* Chains.
------------------------------------------

Thymocytes were enriched for the CD4^−^8^−^ subset by negative depletion of CD4/CD8^+^ cells using Dynabeads (Dynal). For extracellular/intracellular double staining, cells were first incubated with culture supernatant of mAb 2.4G2 to block FcRII/III receptors. Cells were then stained with FITC-conjugated anti-CD25, PE-conjugated anti-CD44, and CyChrome-conjugated anti-CD4 and anti-CD8 at optimal concentration. After washing in PBS, cells were fixed in PBS plus 0.5% paraformaldehyde for 15 min at room temperature, followed by two washing steps in PBS. Cells were then permeabilized in 0.5% saponin for 10 min at room temperature and washed in PBS. Intracellular staining with biotinylated anti--pan TCR-β (H57-597) diluted in PBS/2% FCS plus 0.5% saponin was performed for 30 min at 4°C, washed twice in PBS/2% FCS, and revealed for 30 min at 4°C by streptavidin-APC diluted in PBS/2% FCS plus 0.5% saponin. Cytoplasmic staining was followed by two washing steps in PBS and 15 min on a rocking platform in PBS/2% FCS plus 0.5% saponin on ice. Finally, cells were washed in PBS/2% FCS.

Results and Discussion
======================

Intracellular TCR-β Gene Expression in CD4^−^8^−^ Subsets of Thymocytes.
------------------------------------------------------------------------

We have analyzed thymocytes from wild-type, γc^−/−^ [12](#R12){ref-type="bib"}, pTα^−/−^ [6](#R6){ref-type="bib"}, CD3∈^−/−^ [13](#R13){ref-type="bib"}, and Rag2^−/−^ mice [14](#R14){ref-type="bib"} in order to analyze the effect of each mutation on TCR-β gene expression in small CD25^+^44^−^ cells. The subset distribution among CD4^−^8^−^ cells according to CD44 and CD25 expression is shown in [Fig. 1](#F1){ref-type="fig"}. Wild-type and γc^−/−^ mice exhibit a similar phenotype except for an elevated proportion of CD44^+^25^+^ cells in the latter due to a partial block at this stage of development in γc^−/−^ mice. pTα^−/−^ mice look similar to CD3∈^−/−^ and Rag2^−/−^ mice, but due to their incomplete block at the CD44^−^25^+^ stage of development, contain more CD44^−^25^−^ cells than the latter two strains. Of these, some 70% are γ/δ T cells [6](#R6){ref-type="bib"}. When intracellular TCR-β expression versus CD25 expression was analyzed in all CD4^−^8^−^ cells, it became clear that wild-type and γc^−/−^ thymocytes express TCR β chains in the majority of cells, but γc^−/−^ thymocytes less so because of an early partial block before TCR-β rearrangement at the CD44^+^25^+^ stage [12](#R12){ref-type="bib"}. In these two strains, most TCR-β expression was present in CD25^−^ cells. In contrast, in pTα^−/−^ and CD3∈^−/−^ mice, most TCR-β expression was found in CD25^+^ cells, although less completely so in pTα^−/−^ mice because of a partial developmental block at the CD25^+^44^−^ stage resulting in a population of CD25^−^44^−^ cells, of which up to 70% are γ/δ T cells. Of these γ/δ T cells, up to 25% expressed cytoplasmic TCR β chains [15](#R15){ref-type="bib"}, which accounts for the cytoplasmic TCR-β staining in the CD25^−^ cells in pTα^−/−^ mice ([Fig. 2](#F2){ref-type="fig"} A). There is naturally no TCR-β expression in Rag2^−/−^ mice ([Fig. 2](#F2){ref-type="fig"}). However, this picture changed, to some extent, when the analysis was performed on smaller cells where the proportion of TCR-β^+^ cells among CD25^+^ cells was significantly decreased in wild-type and γc^−/−^ mice but not at all or only marginally in pTα^−/−^ and CD3∈^−/−^ mice ([Fig. 2](#F2){ref-type="fig"} B). What is also apparent in [Fig. 2](#F2){ref-type="fig"} B is that the proportion of TCR-β^1^ cells among small CD25^+^ cells is significantly smaller in wild-type and γc^−/−^ mice, while it is larger in pTα^−/−^ and CD3∈^−/−^ mice. This is due to the fact that in CD25^+^ cells from pTα^−/−^ and CD3∈^−/−^ mice, TCR-β rearrangement proceeds further than in normal mice [16](#R16){ref-type="bib"} [17](#R17){ref-type="bib"}. It is also clear from [Fig. 2a](#F2){ref-type="fig"} and [Fig. b](#F2){ref-type="fig"}, that CD25^+^ cells in wild-type and γc^−/−^ mice express on average higher TCR-β levels than CD25^+^ cells from pTα^−/−^ and CD3∈^−/−^ mice, and that with regard to this parameter there is no significant difference between CD25^+^ cells from pTα^−/−^ and CD3∈^−/−^ cells. Actually, there is a continuous spectrum of TCR-β expression rather than a discrete peak, which would be expected from a population of cells that undergoes TCR-β rearrangement and begins to express productive genes. Nevertheless, there is no doubt that the staining is specific, since there is no staining in the same population of cells in Rag2^−/−^ mice ([Fig. 2](#F2){ref-type="fig"}), and also because an irrelevant control antibody of the same Ig class does not stain in all different mouse strains (data not shown). Thus, all differences that exist between wild-type and CD3∈^−/−^ mice with regard to TCR-β expression in CD25^+^ cells can be attributed to defective signaling by the pre-TCR rather than to an independent control of TCR-β expression by the CD3 complex alone.

We have focused on TCR-β expression in small CD25^+^44^−^ cells only, and it is clear that in this thymocyte subset the proportion of cells expressing TCR-β in their cytoplasm is much smaller than in a population that contains CD25^+^ as well as CD44^+^ cells, due to the presence of CD44^+^ NK T cells in the latter population that express α/β TCRs on their cell surface [11](#R11){ref-type="bib"} and were included in previous analyses [8](#R8){ref-type="bib"}. The NK T cell population is likely to be absent in lck^−/−^, ζ^−/−^ mice because it is a highly selected population that requires signaling through the CD3 complex. Thus, this population would depend on signaling by the α/β TCR rather than just by p56^lck^ and ζ chains, as suggested by Wurch et al. [8](#R8){ref-type="bib"}. The NK T cell population, for reasons so far unknown, is absent in the pTα^−/−^ mice [18](#R18){ref-type="bib"}. Moreover, the CD25^+^44^−^ subset contains a population of pre-TCR--dependent large cells that apparently was included in previous studies [8](#R8){ref-type="bib"}. If one eliminates these populations of cells from analysis, one nevertheless finds differences in the proportion of CD25^+^ cells expressing TCR-β, as well as in the level of TCR-β per cell between wild-type and CD3∈^−/−^ mice: in the former, fewer CD25^+^ cells express TCR-β and at higher levels compared with CD3∈^−/−^ mice. However, the same difference is also noted between wild-type and pTα^−/−^ mice, indicating that this difference is dependent on signal transduction by the pre-TCR rather than signal transduction by p56^lck^ and CD3ζ in the absence of the pre-TCR, as suggested previously [8](#R8){ref-type="bib"} [9](#R9){ref-type="bib"}.

In summary, analysis of TCR-β expression in CD25^+^ cells argues against the notion that levels of TCR-β are upregulated by a pro-TCR rather than the pre-TCR. Rather, they demonstrate that it is the pre-TCR complex in which CD3 signal transducing molecules exert their biological function for the first time in the development of α/β lineage cells.
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![Representative FACS^®^ staining profile of CD4^−^8^−^ thymocytes from C57BL/6 (WT), γc^−/−^, pTα^−/−^, CD3∈^−/−^, and Rag2^−/−^ mice. Thymocytes were double stained for CD25 and CD44 surface antigens as described. The percentages of cells in each quadrant are indicated.](JEM990313.f1){#F1}
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Intracellular staining for TCR-β in CD4^−^8^−^ thymocytes from C57BL/6 (WT), γc^−/−^, pTα^−/−^, CD3∈^−/−^, and Rag2^−/−^ mice. (A) Total CD4^−^8^−^ cells were surface stained with anti-CD25; cytoplasmic staining was performed with anti--pan TCR-β (H57) antibodies. (B) Intracellular TCR-β expression in gated small CD25^+^4^−^8^−^ thymocytes.
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